L. Tschetter

发表

Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: A phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51

D. Kurtz, K. Rowland, S. Geyer, 2007, Leukemia & lymphoma.

Phase III trial of recombinant interferon gamma in complete responders with small-cell lung cancer.

J. Jett, J. Krook, John Q. Su, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Results of a planned interim toxicity analysis with trimodality therapy, including carboplatin AUC = 4, paclitaxel, 5-fluorouracil, amifostine, and radiation for locally advanced esophageal cancer: preliminary analyses and treatment recommendations from the North Central Cancer Treatment Group

K. Rowland, S. Alberts, M. Mahoney, 2004, International seminars in surgical oncology : ISSO.

Gemcitabine, 5‐fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma

S. Alberts, M. Mahoney, P. Flynn, 2005, Cancer.

Interleukin-1 genetic polymorphisms and their relationship to the cancer anorexia/weight loss syndrome in metastatic gastric and gastroesophageal junction adenocarcinoma.

N. Foster, S. Dakhil, A. Jatoi, 2007, The journal of supportive oncology.

Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia.

T. Habermann, L. Hartmann, H. Wieand, 1997, The New England journal of medicine.

Randomized trial of dietician counseling to try to prevent weight gain associated with breast cancer adjuvant chemotherapy.

J. O'fallon, C. Loprinzi, A. Miser, 1996, Oncology.

Gemcitabine and ISIS-2503 for patients with locally advanced or metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II trial.

D. Moore, N. Foster, K. Rowland, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Docetaxel and capecitabine in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: a phase II study from the North Central Cancer Treatment Group.

N. Foster, S. Dakhil, S. Alberts, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Epidemiologic features of pain in pediatric cancer patients: a co-operative community-based study. North Central Cancer Treatment Group and Mayo Clinic).

J. O'fallon, T. Goh, A. Miser, 1991, The Clinical journal of pain.

Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.

J. Sloan, C. Loprinzi, J. Kugler, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer.

H. Wieand, J. Krook, M. O’connell, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment Group.

H. Wieand, J. Krook, M. O’connell, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II Trial of Paclitaxel/Cisplatin Followed by Surgery and Adjuvant Radiation Therapy and 5-Fluorouracil/Leucovorin for Gastric Cancer (ECOG E7296).

P. Catalano, A. Benson, F. Spitz, 2012, Gastrointestinal cancer research : GCR.

Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial.

J. K. Martin, R. Fitzgibbons, H. Wieand, 1990, Archives of surgery.

Tracking clinical trial accrual strategies and barriers via a Web-based screening tool.

M. Krasna, A. Denicoff, B. Duggan, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: a minimal intervention, randomized multicenter trial in a nonspecialized setting.

R. Hurt, P. Novotny, J. Sloan, 2003, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

A phase III randomized trial of two different dosing schedules of erythropoietin (EPO) in patients with cancer-associated anemia: North Central Cancer Treatment Group (NCCTG) Study N02C2

P. Novotny, J. Sloan, C. Loprinzi, 2005 .

Lack of effect of coumarin in women with lymphedema after treatment for breast cancer.

P. Novotny, J. Sloan, C. Loprinzi, 1999, The New England journal of medicine.

Evaluation of external-beam radiation therapy plus 5-fluorouracil (5-FU) versus external-beam radiation therapy plus hycanthone (HYC) in confined, unresectable pancreatic cancer.

J. Earle, L. Kvols, J. Krook, 1994, International journal of radiation oncology, biology, physics.

A phase III trial on the therapy of advanced pancreatic carcinoma evaluations of the mallinson regimen and combined 5‐fluorouracil, doxorubicin, and cisplatin

J. Krook, B. Norris, H. Wieand, 1990, Cancer.

Tetracycline to prevent epidermal growth factor receptor inhibitor‐induced skin rashes

P. Novotny, J. Sloan, C. Loprinzi, 2008, Cancer.

Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent carcinoma of the uterine cervix and vagina.

M. J. Webb, J. Kugler, H. Wieand, 1995, Gynecologic oncology.

A randomized phase II trial of amonafide or trimetrexate in patients with advanced non‐small cell lung cancer. A trial of the north central cancer treatment group

J. Jett, J. Krook, R. Morton, 1993, Cancer.

A phase ii study of the combination of etoposide and cisplatin in the therapy of advanced gastric cancer

H. Wieand, R. Hahn, H. Wieand, 1990, Cancer.

Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis

D. Schaid, J. Ingle, J. Krook, 1991, Cancer.

Transdermal clonidine for ameliorating post-orchiectomy hot flashes.

J. O'fallon, R. Goldberg, C. Loprinzi, 1994, The Journal of urology.

Alternating Chemotherapy With or Without VP‐16 in Extensive‐Stage Small‐Cell Lung Cancer

J. O'fallon, J. Jett, J. Laurie, 1989, American journal of clinical oncology.

Phase II Evaluation of Continuous-Infusion 5-Fluorouracil, Leucovorin, Mitomycin-C, and Oral Dipyridamole in Advanced Measurable Pancreatic Cancer: A North Central Cancer Treatment Group Trial

R. Goldberg, P. Burch, C. Cobau, 2000, American journal of clinical oncology.

Combined levamisole with recombinant interleukin-2 (IL-2) in patients with advanced renal cell carcinoma: a phase II study.

J. Krook, J. Kugler, S. Nair, 1998, American journal of clinical oncology.

Phase II study of 2-chlorodeoxyadenosine in combination with chlorambucil in previously untreated B-cell chronic lymphocytic leukemia.

J. Krook, A. Tefferi, T. Witzig, 1999, American journal of clinical oncology.

Combined doxorubicin and alpha‐interferon therapy of advanced hepatocellular carcinoma

H. Wieand, J. Krook, M. O’connell, 1993, Cancer.

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.

J. Laurie, M. O’connell, H. Wieand, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A North Central Cancer Treatment Group Phase II Trial of Topotecan in Relapsed Gliomas

B. Scheithauer, T. Cascino, J. Buckner, 2000, Investigational New Drugs.

Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention.

R. Hurt, P. Novotny, J. Sloan, 2007, Mayo Clinic proceedings.

Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study.

E. Shaw, J. Jett, C. Loprinzi, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pilot study evaluating local anesthetics administered systemically for treatment of pain in patients with advanced cancer.

C. Loprinzi, J. Mailliard, A. Hatfield, 1997, Journal of pain and symptom management.

Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.

D. Schaid, R. Goldberg, C. Loprinzi, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III study of two different dosing schedules of erythropoietin in anemic patients with cancer.

David P Steensma, P. Novotny, J. Sloan, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase II Trial of Edatrexate, Vinblastine, Adriamycin, Cisplastin, and Filgrastim (EVAC/G-CSF) in Patients With Non–Small-Cell Carcinoma of the Lungs: A North Central Cancer Treatment Group Trial

R. Marks, J. Krook, S. Geyer, 2001, American journal of clinical oncology.

Randomized trial of radiation therapy (RT) plus dibromodulcitol (DBD) versus RT plus BCNU in high grade astrocytoma

B. Scheithauer, J. O'fallon, R. Dinapoli, 1997, Journal of Neuro-Oncology.

Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer.

J. Jett, S. Hillman, D. Northfelt, 2005, International journal of radiation oncology, biology, physics.

Phase II evaluation of recombinant interferon alpha and BCNU in recurrent glioma.

B. Scheithauer, J. O'fallon, T. Cascino, 1995, Journal of neurosurgery.

Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma.

B. Scheithauer, J. O'fallon, R. Arusell, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III evaluation of 4 doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.

D. Schaid, C. Loprinzi, R. Morton, 1994, Oncology.

Efficacy and quality-of-life data are related in a phase II trial of oral chemotherapy in previously untreated patients with metastatic colorectal carcinoma.

D. Sargent, J. Sloan, R. Goldberg, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy a nd Q uality-of-Life D ata A re R elated i n a P hase I I Trial o f O ral C hemotherapy i n P reviously U ntreated P atients With M etastatic C olorectal C arcinoma

D. Sargent, J. Sloan, R. Goldberg, 2002 .

A simple stratification factor prognostic for survival in advanced cancer: the good/bad/uncertain index.

J. Sloan, P. Novotny, C. Loprinzi, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The prevalence of weight concerns in a smoking abstinence clinical trial.

M. Clark, C. Patten, R. Hurt, 2006, Addictive behaviors.

Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5.

P. Novotny, C. Loprinzi, J. Kugler, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation for Locally Advanced Esophageal Cancer: Phase II Results of Preliminary Pharmacologic and Molecular Efforts to Mitigate Toxicity and Predict Outcomes: North Central Cancer Treatment Group (N0044)

H. McLeod, D. Moore, N. Foster, 2007, American journal of clinical oncology.

A randomized trial of interferon‐alpha in cervical dysplasia

J. A. Jefferies, V. Suman, R. Morton, 2001, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent endometrial carcinoma.

S. Cha, J. Krook, M. Veeder, 1995, Gynecologic Oncology.

Myelodysplastic syndrome treatment with danazol and cis‐retinoic acid

R. Morton, J. Mailliard, R. Levitt, 1995, American journal of hematology.

Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors

B. Scheithauer, J. Buckner, J. Krook, 1999, Cancer.

Bolus versus infusion regimens of etoposide and cisplatin in treatment of non-small cell lung cancer: a study of the North Central Cancer Treatment group.

T. Therneau, J. Jett, R. Goldberg, 1990, Journal of the National Cancer Institute.